Byoung Hyuck Kim, MD, PhD

Seoul National University College of Medicine
Seoul, BUS

Education

Mar. 2004 - Feb. 2010   M.D., Seoul National University College of Medicine

Mar. 2012 - Feb. 2014   M.S., Hanyang University College of Medicine, Therapeutic Radiology

Mar. 2018 – Feb. 2020  Ph.D., Seoul National University College of Medicine, Radiation Oncology

Training & Professional Career

Mar. 2011 - Feb. 2015          Resident Physician, Radiation Oncology, Seoul National University Hospital

Sep. 2014                           Visiting Resident, Radiation Oncology, Stanford University Hospital

Mar. 2015 - Apr. 2018           Military Service, Surveillance system research officer, Armed Forces Medical Research Institute

May. 2018 – Feb. 2019         Clinical fellow, Department of Radiation Oncology, SMG-SNU Boramae Medical Center

Mar. 2019 – Present             Clinical Assistant Professor, Department of Radiation Oncology, SMG-SNU Boramae Medical Center

Recent Publications

1. Kim BH, Kwon J (co-first), Kim K, Chie EK, Ha SW. Survival Benefit of Adjuvant Chemoradiotherapy in Patients With Ampulla of Vater Cancer: A Systematic Review and Meta-analysis. Ann Surg. 2015 Jul;262(1):47–52.


2. Kwon J, Kim BH (correspondence), Jung H-W, Besic N, Sugitani I, Wu H-G. The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis. Eur J Cancer. 2016 May;59:34–45.


3. Kim BH, Jung H-W, Seo SH, Shin H, Kwon J, Suh JM. Synergistic actions of FGF2 and bone marrow transplantation mitigate radiation induced intestinal injury. Cell Death Dis. 2018 Mar 7;9(3):383.


4. Kim BH, Kim YJ, Kim MH, Na YR, Jung D, Seok SH, et al. Identification of FES as a novel radiosensitizing target in human cancers. Clin Cancer Res. 2020 Jan;26(1):265-273.

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 2072 - Risk of Clinically Significant Cardiovascular Disease Associated with Postoperative Radiotherapy in Non-Small Cell Lung Cancer Patients Receiving Surgical Resection Followed By Adjuvant Chemotherapy:

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET